Gavi’s Vaccine Investment Strategy (VIS) is the prioritisation process for inclusion of new and underused vaccines that will be made available to countries through our vaccine support programmes.

The development of the world’s first safe and effective malaria vaccine is a truly historic breakthrough. However, to harness its potential to help save many of the more than 600,000 lives claimed by the disease every year, much work still needs…

Gavi's Global Vaccine Impact Conference took place on 13-15 June 2023 in Madrid, Spain. This was our first in-person conference since the pandemic began and a critical milestone to take stock of our progress and performance since the start of our…

When an outbreak of an infectious disease starts to escalate, how should global health organisations decide on if, when and how to launch a response? To this end, Gavi is working with partners to develop a decision-making framework…

Director, Governance